Company Filing History:
1 out of 759 
1 out of 1 
1 out of 33 Years Active: 1998
Title: Ellen Carmichael: Innovator in Viral Research and Molecular Delivery
Introduction
Ellen Carmichael is a notable inventor based in West Hartford, CT, USA, recognized for her significant contributions to the fields of molecular biology and medicine. With a total of two patents to her name, she has focused her research on enhancing targeted delivery mechanisms and developing antiviral agents.
Latest Patents
Carmichael's latest innovations include two groundbreaking patents. The first patent details a method for using a bacterial component to improve the targeted delivery of polynucleotides. This invention revolves around a molecular complex that consists of: (a) a polynucleotide, (b) a carrier constructed from a polynucleotide binding agent and a cell-specific binding agent that binds to a cell's surface molecule and is subsequently internalized into an endosome, and (c) a bacterial component or fragment that lyses the endosome, facilitating the release of the polynucleotide into the cell's cytoplasm. Notably, in this embodiment, the polynucleotide binding agent is polylysine, the cell-specific binding agent is asialoglycoprotein, and the bacterial component employed is listeriolysin O. This molecular complex has promising therapeutic applications for delivering genes and antisense polynucleotides to specific cells in vivo.
Her second patent presents various poly- and oligonucleotides designed to inhibit viral replication, particularly focusing on hepatitis virus replication, such as that of hepatitis B virus (HBV). The patent outlines several antiviral oligonucleotides which hybridize to critical regions of viral nucleic acids, including the RNA primer-binding region and mRNA encoding essential proteins. These innovative compounds not only serve as potential therapeutic agents but can also be utilized for the detection of viral nucleic acids in affected cells.
Career Highlights
Ellen Carmichael has had an impactful career, contributing her expertise to significant research institutions. She has worked at the University of Connecticut, where her foundational research laid the groundwork for her innovative patents. Additionally, she has been associated with Targetech, Inc., a wholly owned subsidiary of the Immune Response, enhancing her experience in the biotechnology sector.
Collaborations
Throughout her career, Carmichael has collaborated with esteemed colleagues, including George Y. Wu and Catherine H. Wu. These professional relationships have fostered innovative research and contributed to her success in the field.
Conclusion
Ellen Carmichael is a brilliant inventor whose work in molecular delivery systems and antiviral therapies showcases her dedication to addressing significant medical challenges. By combining her extensive knowledge and innovative spirit, she has established herself as a prominent figure in the field of biotechnology. Her patents not only pave the way for novel treatment options but also highlight the importance of targeted therapies in modern medicine.